Therefore, a unique relationship seems to exist between ERCC2 mutations and bladder cancer tumorigenesis, and additional work will be needed to define the molecular role of ERCC2 mutations as a bladder cancer driver. The gene discussed is ERCC2; the disease is urinary bladder cancer.